Back
DELHI HIGH COURT
PRATHIBA M.SINGH
Vinay Jaidka – Appellant
Versus
Chief Secretary – Respondent
| Table of Content |
|---|
| 1. petitioner's health situation and drug necessity (Para 2 , 3 , 4) |
| 2. court's inquiry and drug supply situation (Para 5 , 7) |
| 3. need for holistic approach to drug allocation (Para 8 , 9 , 10) |
| 4. court's directives for immediate action (Para 11 , 12) |
JUDGMENT
Prathiba M. Singh, J. (Oral)--This hearing has been done through video conferencing.
2. The present petition is a loud cry by an advocate practising in Delhi who is suffering from COVID-19 for being provided with Remdesivir injection which has been prescribed to him.
3. The Petitioner was detected with COVID-19 on 13th April, 2021. Since the Petitioner's condition was not improving in home isolation, he was admitted to Rescue Hospital, Dwarka, New Delhi. He got his CT scan conducted and was found to also be suffering from pneumonia. On 21st April, 2021, the Petitioner was prescribed Remdesivir injection (100 mg) to be given in six doses. Six valuable days have already passed by. The Petitioner has been able to arrange three doses from outside market sources and today, ld. Counsel for the Petitioner submits that he requires three more vials for his treatment.
4. It is a matter of which judicial notice can be
The court mandated that the immediate availability of essential drugs like Remdesivir must be ensured during public health emergencies, stressing the need for systemic improvements in drug allocation....
COVID-19 pandemic - frustration and harassment due to non-availability of Remdesivir, which is a prescribed drug for COVID-19 patients - Nodal Officer of GNCTD, who is dealing with Remdesivir, as als....
The court emphasized the necessity of efficient drug distribution, transparency in hospital admission reporting, and timely insurance processing to ensure patient care during the COVID-19 pandemic.
The main legal point established is the need for immediate availability of essential drugs, such as Tocilizumab, for critically ill COVID-19 patients and the provisions of the Patents Act allowing fo....
During a national emergency, the government can exercise powers under the Patents Act to ensure the availability of essential drugs, emphasizing public health needs amid a pandemic.
Covid -19 – Second wave – Directions issued to State and Central Government to make available Remdesivir, Oxygen and''RT-PCR'' and "Rapid Antigen" tests' - Every legal right has a corresponding legal....
Urgent assessment and supply of essential drugs in public health emergencies.
Court emphasizes urgency and coordinated efforts to ensure availability of critical medicine for COVID-19 patients while addressing broader supply chain issues.
The court opined that to prevent multiplicity of litigation, a writ petitioner may file an application in an existing case involving similar issues.
The main legal point established is the court's intervention to address the shortage of Tocilizumab 400 MG for COVID-19 patients in India, emphasizing the need for the manufacturer to meet the demand....
An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers
Please visit our Training & Support
Center or Contact Us for assistance
Scan Me!
India’s Legal research and Law Firm App, Download now!
For Daily Legal Updates, Join us on :
Back to top
